MONEY

Inhibikase Therapeutics director Bellini acquires $2m in stock

Tomas Kauer - ModeratorTomas Kauer - Moderator
Oct 24, 2024 - 08:00
Inhibikase Therapeutics director Bellini acquires $2m in stock
Read More

Tags:

Previous Article

106 Questions You Can Ask Your Data with AI Chat 

Next Article

Mother sues AI chatbot company Character.AI, Google over son's suicide

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Tomas Kauer - Moderator
Tomas Kauer - Moderator

Related Posts

Haleon stock favored for top-line growth, outperformance cited by Morgan Stanley

Haleon stock favored for top-line growth, outperformanc...

Tomas Kauer - Mode... Sep 20, 2024

Peter Thiel sells over $457 million in Palantir Technologies stock

Peter Thiel sells over $457 million in Palantir Technol...

Tomas Kauer - Mode... Oct 2, 2024

Banzai Announces Closing of $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Banzai Announces Closing of $5 Million Private Placemen...

Tomas Kauer - Mode... Sep 27, 2024